Clearly, PDL-1 levels in the lung of tumor-bearing mice decreased by approximately 2-fold, while the PDL-1 levels in the tumor nodules increased by approximately 1.4-fold, upon ProAgio treatment (Figure 5A–C). This evidence concerns the gene CD274 and neoplasm.